In conclusion, this study has documented that patients with NDD-CKD have higher serum levels of sFas, IL-6, IFN-γ, C-reactive protein, iPTH, and EPO/Hb ratio than healthy subjects. The gene discussed is IL6; the disease is Neurodevelopmental delay.